跳至主要内容
临床试验/NCT02629406
NCT02629406已完成不适用

Studies on the Adaptive Responses (Cardiovascular, Respiratory and Angiogenetic) to Hypoxia in Patients With Type 1 Diabetes Compared to Controls

Karolinska University Hospital1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2015年11月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
30
试验地点
1
主要终点
Endothelial precursor cell account (EPC)

研究概览

简要总结

The general aim of this study is to define the response to hypoxic challenge in patients with diabetes. The investigation will provide response for different questions that are central for explaining the development of complications in diabetes

  • have patients with diabetes an impaired reaction to adapt to hypoxia
  • what consequence has hypoxia challenge on respiratory and on cardiovascular regulation in patients with diabetes
  • what consequence has diabetes on the angiogenetic response to hypoxia

详细描述

Complications of diabetes represent the main concern for modern diabetes therapy, and it has become a priority to further characterise the pathophysiological mechanisms of these complications to ensure the development of novel rational therapeutic strategies.

Although the prolonged exposure of tissues to hyperglycaemia is the primary causative factor for chronic diabetes complications, it has recently become increasingly evident that hypoxia also plays an important role in all diabetes complications . A low tissue concentration of oxygen in diabetes is the consequence of several mechanisms (e.g., deficient blood supply because of micro- and macro-vascular disease , poor local oxygen diffusion because of local oedema, or as the result of increased oxygen consumption).

Adaptive responses of cells to hypoxia are mediated by Hypoxia-Inducible Factor 1 (HIF), which is a heterodimeric transcription factor that is composed of and subunits, which are both constitutively expressed in mammalian cells. The regulation of HIF activity is critically dependent on subunit degradation in normoxia. Under hypoxic conditions, HIF-1 is stabilised, binds to HRE (hypoxic responsive elements) and up-regulates a gene series that is involved in angiogenesis, glycolytic energy metabolism, cell proliferation, and survival, which enables cells to adapt to reduced oxygen availability. It is estimated that that more than 800 genes are direct HIF targets . HIF-1 is central for expression of multiple angiogenic growth factors (reviewed by[6]), endothelial progenitor cells (EPC) recruitment . Recently, it has been proposed that microRNAs (ex. mir210) also mediate some HIF-1 functions .

Several pieces of evidence point to a defective response of diabetic tissues to hypoxia. An impaired hypoxia response is present in all tissues investigated in diabetic animal and diabetic patients. Hyperglycaemia directly represses HIF stability and function at multiple levels, a mechanism that is not completely understood.

An impaired reaction to hypoxia in diabetes might have important consequences in acute hypoxic challenges as acute heart infarction, stroke, limb ischemia but also in subtle regulation of cardiovascular and respiratory system as a consequence of autonomic neuropathy with potential severe prognostic effect on late cardiovascular events . Interventional studies have addressed the cardiovascular responses to intermittent hypoxia (IH) compared with normoxia exposure in patients with diabetes . However in order to establish the appropriateness of the cardiovascular reaction to hypoxia in diabetes it is a need to investigate the cardiorespiratory responses towards IH in patients with diabetes compared with matched non diabetic control subjects. Moreover it is essentially to establish the angiogenetic response in the same experimental design. The hypothesis for this study is that both the cardiorespiratory reaction mediated through autonomic nervous system and angiogenetic response are impaired in patients with diabetes as a consequence of an impaired HIF reaction as seen in other tissues .

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
20 Years 至 50 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with typ1 diabetes with a duration of the disease between 10-20 years (HbA1c ≥ 65 mmol /l)
  • Healthy controls matched for age, BMI and gender on group bases.

排除标准

  • Infections during the last month
  • Major cardiovascular complications such as coronary heart disease, unstable or stable angina, myocardial infarction, ventricular arrhythmias, and atrial fibrillation in the last 3 months
  • Decompensated congestive heart failure or functional class 3-
  • Therapy with b-blockers
  • Severe hypertension (180 mmHg systolic or 110 mmHg diastolic blood pressure
  • Proliferative retinopathy.
  • Obvious sign for diabetic neuropathy (decreased/absent sensitivity to 10 g monofilament, vibration, plantar reflex)
  • Definite autonomic dysfunction
  • HbA1c ≥ 108 mmol/l
  • Any concomitant disease or condition that may interfere with the possibility for the patient to comply with or complete the study protocol
  • History of alcohol or drug abuse
  • Participant in another ongoing pharmacological study
  • Unwillingness to participate following oral and written information
  • Subjects with any other severe acute or chronic medical or psychiatric condition that make the subject inappropriate for the study in the judgment of the investigator

结局指标

主要结局

Endothelial precursor cell account (EPC)

时间窗: 24 hours

The absolute amount of endothelial precursor cells in 10 ml of blood

次要结局

未报告次要终点

研究者

发起方
Karolinska University Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Neda Rajamand Ekberg

M.D, PhD

Karolinska University Hospital

研究点 (1)

Loading locations...

相似试验

Studies on the Adaptive Responses to Hypoxia | 临床试验